Environmental endocrine disruptors promote invasion and metastasis of SK-N-SH human neuroblastoma cells

Oncology Reports

Volumn 23, Issue 1, 2010, Pages 129-139

  Zhu, Haitao ^a   Zheng, Jicui ^a   Xiao, Xianmin ^a   Zheng, Shan ^a   Dong, Kuiran ^a   Liu, Jiangbin ^a   Wang, Yang ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

17 estradiol; Bisphenol a; Di(2 ethylhexyl) phthalate; Estrogen receptor; Matrix metalloproteinases; Metastasis; Neuroblastoma; Phosphoinositide 3 kinase pathway; Protein serine threonine kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4,4' ISOPROPYLIDENEDIPHENOL; COMPLEMENTARY DNA; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN RECEPTOR BETA; FULVESTRANT; GELATINASE A; GELATINASE B; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PROTEIN KINASE B; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; METASTASIS; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TUMOR; DIETHYLHEXYL PHTHALATE; ENDOCRINE SYSTEM; ESTRADIOL; ESTROGENS, NON-STEROIDAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEUROBLASTOMA; PHENOLS; PLASTICIZERS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 76049118214     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000614     Document Type: Article

References (50)

1. McHugh K: Renal and adrenal tumours in children. Cancer Imaging 7: 41-51, 2007.
2. Park JR, Eggert A and Caron H: Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 55: 97-120, 2008.
3. Maris JM, Hogarty MD, Bagatell R and Cohn SL: Neuroblastoma. Lancet 369: 2106-2120, 2007.
4. Brodeur GM: Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216, 2003.
5. Schwab M, Westermann F, Hero B and Berthold F: Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 4: 472-480, 2003.
6. Ara T and DeClerck YA: Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 25: 645-657, 2006.
7. Vandenberg LN, Hauser R, Marcus M, Olea N and Welshons WV: Human exposure to bisphenol A (BPA). Reprod Toxicol 24: 139-177, 2007.
8. Makey CM, Rubin BS, Soto AM and Sonnenschein C: Endocrine disruptors: from Wingspread to environmental developmental biology. J Steroid Biochem Mol Biol 83: 235-244, 2002.
9. Mello-da-Silva CA and Fruchtengarten L: Environmental chemical hazards and child health. J Pediatr 81: S207-S211, 2005.
10. Vom Saal FS and Myers JP: Bisphenol A and risk of metabolic disorders. JAMA 300: 1353-1355, 2008.
11. Hotchkiss AK, Rider CV, Blystone CR, et al: Fifteen years after 'Wingspread'-environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicol Sci 105: 235-259, 2008.
12. Schoeters G, Den Hond E, Dhooge W, van Larebeke N and Leijs M: Endocrine disruptors and abnormalities of pubertal development. Basic Clin Pharmacol Toxicol 102:168-175, 2008.
13. Prins GS: Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer 15: 649-656, 2008.
14. Gray J, Evans N, Taylor B, Rizzo J and Walker M: State of the evidence: the connection between breast cancer and the environment. Int J Occup Environ Health 15: 43-78, 2009.
15. Hauser R and Calafat AM: Phthalates and human health. Occup Environ Med 62: 806-818, 2005.
16. Palanza P, Gioiosa L, vom Saal FS and Parmigiani S: Effects of developmental exposure to bisphenol A on brain and behavior in mice. Environ Res 108: 150-157, 2008.
17. Maffini MV, Rubin BS, Sonnenschein C and Soto AM: Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol 254-255: 179-186, 2006.
18. Richeter CA, Birnbaum LS, Farabollini F, et al: In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24: 199-224, 2007.
19. Swan SH: Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 108: 177-184, 2008.
20. Latini G, Del Vecchio A, Massaro M, Verrotti A and De Felice C: Phthalate exposure and male infertility. Toxicology 226: 90-98, 2006.
21. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB and Melzer D: Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300: 1303-1310, 2008.
22. Takeshita A, Inagaki K, Igarashi-Migitaka J, Ozawa Y and Koibuchi N: The endocrine disrupting chemical, diethylhexyl phthalate, activates MDR1 gene expression in human colon cancer LS174T cells. J Endocrinol 190: 897-902, 2006.
23. Buteau-Lozano H, Velasco G, Cristofari M, Balaguer P and Perrot-Applanat M: Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-depenedent mechanism. J Endocrinol 196: 399-412, 2008.
24. Zheng J, Xiao X, Liu J, Zheng S, Yin Q and Yu Y: Growth-promoting effect of environmental endocrine disruptors on human neuroblastoma SK-N-SH cells. Environ Toxicol Phar 24: 189-193, 2007.
25. Zhu H, Xiao X, Zheng J, Zheng S, Dong K and Yu Y: Growth-promoting effect of bisphenol A on neuroblastoma in vitro and in vivo. J Pediatr Surg 44: 672-680, 2009.
26. Zhu H, Xiao X, Zheng J, Zhou G and Wang Y: Growth-promoting effect of di-2-ethylhexyl phthalate on human neuroblastoma cells. Fudan Univ J Med Sic 36: 407-412, 2009.
27. Papoutsi Z, Zhao C, Putnik M, Gustafsson JA and Dahlman-Wright K: Binding of estrogen receptor {alpha}/{beta} heterodimers to chromatin in MCF-7 cell. J Mol Endocrinol 43: 65-72, 2009.
28. Duffy MJ and McCarthy K: Matrix metalloproteinases in cancer: prognostic markers and targets for therapy. Int J Oncol 12: 1343-1348, 1998.
29. Cheng Y, Dong Q, Sun LR, Yang CM and Jiang BX: Correlation between expression of MMP-2, MMP-9, TIMP-2, TIMP-1 and metastasis of neuroblastoma. Zhonghua Zhong Liu Za Zhi 27: 164-166, 2005.
30. Dang VH, Nguyen TH, Lee GS, Choi KC and Jeung EB: In vitro exposure to xenoestrogens induces growth hormone transcription and release via estrogen receptor-depedent pathways in rat pituitary GH3 cells. Steroids 74: 707-714, 2009.
31. Park SH, Kim KY, An BS, Choi JH, Jeung EB, Leung PC and Choi KC: Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38. J Reprod Dev 55: 23-29, 2009.
32. Welshons WV, Nagel SC and vom Saal FS: Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147: S56-S69, 2006.
33. Dalmasso P, Pastore G, Zuccolo L, Maule MM, Pearce N, Merletti F and Magnani C: Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in northwest Italy, 1967-2001. A report of the childhood cancer registry of piedmont. Haematologica 90: 1197-1204, 2005.
34. Maggi R, Poletti A, Casulari LA, Pimpinelli F, Piva F, Zanisi MR and Martini L: Effects and metabolism of steroid hormones in human neuroblastoma cells. Steroids 63: 257-262, 1998.
35. Biedler JL, Helson L and Spengler BA: Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33: 2643-2652, 1973.
36. Ba F, Pang PK, Davidge ST and Benishin CG: The neuroprotective effects of estrogen in SK-N-SH neuroblastoma cell cultures. Neurochem Int 44: 401-411, 2004.
37. Vihinen P, Ala-aho R and Kahari VM: Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 5: 203-220, 2005.
38. Ribatti D, Marimpietri D, Pastorino F, Brignole C, Nico B, Vacca A and Ponzoni M: Angiogenesis in neuroblastoma. Ann N Y Acad Sci 1028: 133-142, 2004.
39. Ball LJ, Levy N, Zhao X, Griffin C, Tagliaferri M, Cohen I, Ricke WA, Speed TP, Firestone GL and Leitman DC: Cell type-and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements. Mol Cell Endocrinol 299: 204-211, 2009.
40. Yanagihara N, Toyohira Y and Shinohara Y: Insights into the pharmacological potential of estrogens and phytoestrogens on catecholamine signaling. Ann N Y Acad Sci 1129: 96-104, 2008.
41. Ascenzi P, Bocedi A and Marino M: Structure-function relationship of estrogen receptor α and β: impact on human health. Mol Aspects Med 27: 299-402, 2006.
42. Recchia AG, Vivacqua A, Gabriele S, Carpino A, Fasanella G, Rago V, Bonofiglio D and Maggiolini M: Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha. Food Addit Contam 21: 134-144, 2004.
43. Bolli A, Galluzzo P, Ascenzi P, et al: Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor alpha-dependent rapid signals. IUBMB Life 60: 843-852, 2008.
44. Engelman JA, Luo J and Cantley LC: The evolution of phosphatidylinositol- 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7: 606-619, 2006.
45. Yoeli-Lerner M and Toker A: Akt/PKB signaling in cancer: a function in cell motility and invasion. Cell Cycle 5: 603-605, 2006.
46. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 480-501, 2002.
47. Kalkman HO: The role of phosphatidylinositide 3-kinaseprotein kinase B pathway in schizophrenia. Pharmacol Ther 110: 117-134, 2006.
48. Franke TF: PI3K/Akt: getting it right matters. Oncogene 27: 6473-6488, 2008.
49. Tokunaga E, Oki E, Egashira A, Sadanaga N, Morita M, Kakeji Y and Maehara Y: Deregulation of the Akt pathway in human cancer. Curr Cancer Drug Targets 8: 27-36, 2008.
50. Vasconsuelo A, Milanesi L and Boland R: 17Beta-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway. J Endocrinol 196: 385-397, 2008.